Antimalarial antibody repertoire defined by plasma IG proteomics and single B cell IG sequencing
Coelho CH., et al.
JCI Insight
October 2020
Authors and Affiliates
Camila H Coelho 1, Steven T Nadakal 1, Patricia A Gonzales Hurtado 1, Robert Morrison 1, Jacob D Galson 2, Jillian Neal 1, Yimin Wu 3, C Richter King 3, Virginia Price 3, Kazutoyo Miura 4, Sharon Wong-Madden 1, Justin Ya Dortichamou 1, David L Narum 1, Nicholas J MacDonald 1, Maryonne Snow-Smith 1, Marissa Vignali 5, Justin J Taylor 6, Marie-Paule Lefranc 7, Johannes Trück 8, Carole A Long 4, Issaka Sagara 9, Michal Fried 1, Patrick E Duffy 1;
1 Laboratory for Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, NIH, Rockville, United States of America.
2 Department of Pediatrics, University Children's Hospital Zürich, Zürich, Switzerland.
3 PATH's Malaria Vaccine Initiative, Washington DC, United States of America.
4 Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, NIH, Rockville, United States of America.
5 Adaptive Biotechnologies, Inc., Seattle, United States of America.
6 Fred Hutchinson Cancer Research Center, University of Washington, Seattle, United States of America.
7 Institut de Génétique Humaine, Université Montpellier 2, Montpellier, France.
8 Department of Immunology, University Children's Hospital Zürich, Zürich, Switzerland.
9 Malaria Research and Training Center, University of Bamako, Bamako, Mali.